ACXP
Acurx Pharmaceuticals Inc

2,221
Mkt Cap
$15.99M
Volume
1.01M
52W High
$21.00
52W Low
$1.33
PE Ratio
-0.94
ACXP Fundamentals
Price
$5.60
Prev Close
$6.63
Open
$6.52
50D MA
$2.67
Beta
1.01
Avg. Volume
51,656.08
EPS (Annual)
-$5.32
P/B
2.50
Rev/Employee
$0.00
$3.82
Loading...
Loading...
News
all
press releases
Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?
The mean of analysts' price targets for Acurx Pharmaceuticals (ACXP) points to a 226.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?
Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.
Zacks·5d ago
News Placeholder
AI, Diagnostics and Next-Gen Materials Drive Innovation Push Across Emerging Growth Stocks
A wave of developments across emerging technology and life sciences companies underscores how artificial intelligence, advanced diagnostics, and next-generation biomaterials are converging to reshape several high-growth sectors. $ISPC, $AIFF, $KBLB, $BIAF, $ACXP, $KIDZ
24-7 Market News·9d ago
News Placeholder
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business...
PR Newswire·9d ago
News Placeholder
Best Pharmaceutical Stocks To Follow Now - March 11th
Eli Lilly and Company, Pfizer, Vertex Pharmaceuticals, AbbVie, Abbott Laboratories, Acurx Pharmaceuticals, and Novo Nordisk A/S are the seven Pharmaceutical stocks to watch today, according to...
MarketBeat·11d ago
News Placeholder
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today?
Acurx Pharmaceuticals Inc shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news during the session.read more...
Benzinga·11d ago
News Placeholder
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection Acurx...
PR Newswire·13d ago
News Placeholder
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update Acurx Pharmaceuticals to Discuss Full Year and...
PR Newswire·1mo ago
News Placeholder
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?
Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.
Zacks·2mo ago
News Placeholder
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals Health~Holland Awards Another Innovative Research...
PR Newswire·4mo ago
<
1
2
...
>

Latest ACXP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.